Table 2.
Correlation between inflammatory infiltrate and CX3CR1 polymorphism§.
| AMI | NCC | |||||
|---|---|---|---|---|---|---|
| V/V249 13/25 (52)* |
V/I249 10/25 (40) |
I/I249 2/25 (8) |
V/V249 2/22 (9) |
V/I249 12/22 (55) |
I/I249 8/22 (36) |
|
| CD3 | ||||||
| Neg./weak | 0 | 0 | 1 | 1 | 7 | 7 |
| Pos. moderate | 0 | 1 | 1 | 1 | 5 | 0 |
| Strong | 13 | 9 | 0 | 0 | 0 | 0 |
| CD20 | ||||||
| Neg./weak | 12 | 9 | 0 | 2 | 12 | 7 |
| Pos. moderate | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong | 0 | 0 | 2 | 0 | 0 | 0 |
| CXCL1 | ||||||
| Neg./weak | 0 | 0 | 0 | 1 | 12 | 7 |
| Pos. moderate | 1 | 1 | 2 | 1 | 0 | 0 |
| Strong | 12 | 9 | 0 | 0 | 0 | 0 |
| CXCR1 | ||||||
| Neg./weak | 0 | 0 | 1 | 1 | 7 | 7 |
| Pos. moderate | 0 | 1 | 1 | 0 | 5 | 0 |
| Strong | 13 | 9 | 0 | 1 | 0 | 0 |
§The table shows the IHC results in the coronary plaque of AMI and control patients (NCC), correlated to the presence of CX3CR1 V249I polymorphism in the same groups. *In parentheses, the percentage of patients was reported.